Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications (AAPs) in Major Depressive Disorder (MDD): The Patient Perspective.
HomePublicationsAssessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications (AAPs) in Major Depressive Disorder (MDD): The Patient Perspective.
Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications (AAPs) in Major Depressive Disorder (MDD): The Patient Perspective.
2015 US Psychiatric and Mental Health Congress
Hartry, A. | Francois, C. | Llorca, P. M. | Lancon, C. | dibenedetti, D.B. | Brown, M. |
Volume: ,
Issue: ,
Pages: ,
